Skip to main content

Menu

Select a tool from the sidebar

Create your free account now!

Sign in to customize and use tools on the sidebar.

GSK plc logo
GSK.L
GSK plc
13:26:33
1936.5 £
0.0000 (%0.00)
Previous Close: 1923
Day Low1917.5
Day High1942.5
Bid
Ask

GSK.L: GSK plc Stock Live Price Graph

Loading chart...
Industry
LSE
Sector
-
Exchange
London Stock Exchange

About the company

GSK plc is a global pharmaceutical and healthcare company, deeply involved in the research, development, production, and commercialization of a diverse range of medicinal and wellness products. Its operations span the United Kingdom, the United States, and numerous other international markets. The company structures its operations across four primary divisions: Pharmaceuticals, Pharmaceutical R&D, Vaccines, and Consumer Healthcare. Within its Pharmaceuticals segment, GSK provides treatments addressing a wide array of therapeutic areas. These include respiratory conditions, HIV, immuno-inflammatory diseases, oncology, viral infections, central nervous system disorders, cardiovascular and urogenital health, metabolic imbalances, bacterial infections, and dermatological issues. The Consumer Healthcare division offers products across categories such as wellness, oral hygiene, nutritional supplements, and skin health. These consumer offerings come in a variety of formats, including oral dosage forms (e.g., tablets, syrups, lozenges, gummies, soft chews, effervescents), topical applications (e.g., gels, creams, patches, lip balms), nasal sprays, and a comprehensive range of oral hygiene products (e.g., toothpastes, mouthwashes, denture care items), alongside other specialized formulations like infant drops and wipes. GSK actively engages in various collaborative ventures. Its collaboration agreements include partnerships with 23andMe, Lyell Immunopharma, Inc., Novartis, Sanofi SA, Surface Oncology, Progentec Diagnostics, Inc., Alector, Inc., and CureVac AG. Additionally, the company maintains strategic alliances with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. Originally established in 1715, the company operated under the name GlaxoSmithKline plc until its rebranding to GSK plc in May 2022. Its corporate headquarters are situated in Brentford, United Kingdom.

Company profile

Employees
68,629
Field of activity
Drug Manufacturers - General

Market News & Analysis

Güçlü Sat
Sat
Nötr
Al
Güçlü Al

Target Price

No analyst target price data is available for this instrument.

Dividend History

Cash dividends

Latest dividend (gross per share)
$17
Highest dividend$17
Average dividend$17
Lowest dividend$17
PaymentGross / shareNet / shareYieldPer 1,000 TRY
-$17$173.58%-

What Is GSK.L? Live GSK.L Prices and Analysis

GSK.L, or GlaxoSmithKline plc, is a British multinational pharmaceutical and healthcare company. Founded in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham, GSK has established itself as a key player in the global healthcare sector. The company focuses on research and development in pharmaceuticals, vaccines, and consumer healthcare products, making it an important entity in the fight against diseases and improving public health. Investors closely follow GSK.L due to its significant market presence and potential for growth in the pharmaceutical sector.

As a publicly traded company, GSK.L is subject to market fluctuations and investor sentiment, which can significantly impact its stock price. Understanding the factors that influence GSK.L is essential for making informed investment decisions.

Market Context

GSK.L is traded on the London Stock Exchange, and its stock price is influenced by various factors, including international trading dynamics, currency fluctuations, and market volatility. The company's performance is often assessed in GBP, but it is also affected by its global operations and sales, which may be denominated in other currencies. Investors should be aware of the potential for volatility due to regulatory changes, competitive pressures, and macroeconomic factors that can impact the healthcare sector.

Why Do GSK.L Prices Rise or Fall?

The stock price of GSK.L can fluctuate for various reasons, reflecting changes in the company's performance, market conditions, and investor sentiment. Some of the key factors include:

  • Earnings Reports: Quarterly and annual earnings can significantly impact stock prices, with positive results often leading to price increases.
  • Drug Approvals: Successful approval of new drugs or vaccines by regulatory authorities can boost investor confidence and stock prices.
  • Market Competition: The entry of new competitors or advancements in existing treatments can affect GSK's market share and profitability.
  • Global Health Trends: Public health crises, such as pandemics, can lead to increased demand for GSK’s products, positively influencing stock prices.
  • Dividend Announcements: Changes in dividend payouts can attract or deter investors, impacting stock price movements.
  • Mergers and Acquisitions: News of potential mergers or acquisitions can create speculation and drive stock prices up or down.
  • Regulatory Changes: Changes in healthcare regulations can have immediate effects on GSK’s operations and stock performance.
  • Market Sentiment: Overall market conditions and investor sentiment towards the pharmaceutical sector can influence GSK.L prices.

Understanding these factors can help investors gauge potential price movements and make informed decisions regarding GSK.L.

Why Is Live GSK.L Price Tracking Important?

Tracking the live price of GSK.L is crucial for investors looking to make timely decisions. Monitoring real-time price changes allows investors to react quickly to market developments and adjust their strategies accordingly. Some key benefits of live price tracking include:

  • Informed Trading Decisions: Access to real-time data helps investors capitalize on price movements.
  • Market Analysis: Analyzing price trends can provide insights into market sentiment and potential future movements.
  • Risk Management: Tracking prices helps investors manage their portfolios and mitigate risks.
  • Investment Timing: Knowing the current price can assist in making better decisions regarding entry and exit points.
  • Performance Evaluation: Live tracking enables investors to assess their investment performance continuously.

What Should You Consider When Trading / Investing in GSK.L?

Investing in GSK.L, like any stock, carries inherent risks. Investors should consider the following factors:

  • Market Conditions: Stay informed about the overall health of the stock market and the pharmaceutical sector.
  • Company Fundamentals: Analyze GSK’s financial health, including earnings, revenue growth, and debt levels.
  • Regulatory Environment: Be aware of any changes in healthcare regulations that may impact GSK’s operations.
  • Volatility: Understand that GSK.L can experience volatility, particularly around earnings reports or product announcements.
  • Global Events: Monitor global health trends and events that may influence GSK’s business.

What Can You Find on the Investvio GSK.L Page?

  • Live Price: Real-time updates on GSK.L stock price.
  • Charts: Interactive charts for technical analysis of price movements.
  • Technical Analysis: Insights into market trends and indicators.
  • News: Latest news and updates related to GSK and the pharmaceutical sector.
  • Earnings Reports: Information on GSK’s financial performance.
  • Dividend Information: Details regarding dividend payouts and history.

Investing in GSK.L offers opportunities for growth, but it also requires careful consideration of various factors. By utilizing the resources available on the Investvio GSK.L page, investors can stay informed and make educated decisions in their trading activities.